CDC Financial, Inc.

Position in CCCC — C4 Therapeutics, Inc.

CIK 2077836 CHICAGO, IL

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,670

New position

Shares Held

1,000

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#138

of 147 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

CDC Financial, Inc. holds $14,144,132 across 3 Biotechnology names. CCCC ranks #3 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	140,130	$13,277,317
2	ZNTL	Zentalis Pharmaceuticals, Inc.	177,762	$862,145
3	CCCC	C4 Therapeutics, Inc. This page	1,000	$4,670

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,670	1,000	—	Shares	Defined	2026-08-14
No filing history on record for this holder in this stock.